Brainsway accelerates international expansion in India

BrainsWay announced the expanded market penetration of its Deep Transcranial Magnetic Stimulation technology in India. After the most recent in a series of successive multisystem orders, Asha Neuromodulation Clinics and its affiliates will own 25 Deep TMS systems, substantially increasing access to BrainsWay’s patented technology for mental health patients suffering from a range of conditions including depression, obsessive-compulsive disorder, and smoking addiction. “We are pleased that our unique form of therapy is gaining real traction in India,” said Hadar Levy, Chief Executive Officer of BrainsWay. “This is further proof of BrainsWay’s strategic commitment to expanding its international footprint, and allows us the ability to make a true difference in the lives of patients in the world’s most populous country. We are proud to partner with the ANC team in making this shared vision a reality.”